Summary 5'-nucleotidase activity, arachidonate metabolism and adenosine uptake were measured in P388 murine leukaemia cells and in a subline resistant to doxorubicin. These membranes related activities were found to be increased in the doxorubicin resistant cell line, compared to the drug sensitive cells. It is suggested that these differences do not play a role in the mechanism of resistance to doxorubicin. Rather they reflect alterations in plasma membrane composition and structure between these cell lines.
have shown that the activity of 5'-nucleotidase of different populations of mouse lymphocytes may vary considerably. Raz et al. (1978) measured the activity of this enzyme in Moloney virus-induced lymphoma, methylcholanthrane-induced lymphoma and their normal parental mouse lymphocytes. They found a marked reduction in the specific activity of 5'-nucleotidase in the lymphoma cells compared to normal lymphocytes. Similar differences in 5'nucleotidase activity were found by Petitou et al. (1978) between human normal donors and leukaemic patients. They have also found a marked decrease in the cell membrane lipid structural order of leukaemic cells compared to normal lymphocytes. These findings suggest a possible relationship between the two phenomena.
We have recently reported that the membrane lipid structural order of doxorubicin-resistant P388 cells is higher than that measured in the parent doxorubicin-sensitive P388 cell line (Ramu et al., 1983a) . This change is apparently the result of the difference in membrane lipid composition (Ramu et al., 1983b) . Therefore, we have studied whether the increase in membrane lipid structural order, found in doxorubicin-resistant P388 cells is also associated with an increase in the cell 5'-nucleotidase activity.
As changes in cell membrane lipid composition and structural order may affect cell membraneassociated activities, we have also compared in these cell lines the metabolism of arachidonate and the uptake of adenosine.
doxorubicin-sensitive and -resistant P388 cells were compared, measurements were performed with cells harvested on the fourth day of growth.
The sensitivity of both cell lines to doxorubicin was assessed as follows: cells were cultured in the presence of various drug concentrations and the slope of the log cell density versus time plot was calculated by linear regression analysis. The growth rate at each drug concentration was expressed as the percentage of the control growth rate. Dose effect curves were thus produced and were used to determine the concentration of drug effective in inhibiting the growth rate by 50% (ED50). The doxorubicin ED50 for drug-sensitive and drugresistant P388 cells was 2 to 4 x 10-8 M and 1-2 x 10-6 M respectively. No change in drug sensitivity of either cell line was observed during 3 years of continuous in vitro culture. Similarly, the sensitivity of both cell lines to indomethacin and nitro-benzylthioinosine (both from Sigma Chemical Co.), in the presence and absence of doxoribicin, was also measured.
5'-nucleotidase assay Cells were harvested by centrifugation (700g for 10min), washed x 3 in Tris-buffered saline (TBS, Tris-buffer 10 mM, pH 7.8, NaCl 0.9%) and adjusted to 4-6 x 106 cells ml-'. Enzyme activity was assayed by a modification of a previously described method (Reaman et al., 1979 included in the assay to insure its specificity for 5'nucleotidase activity (Belfield & Goldberg, 1968) .
Assay for arachidonate metabolites
Washed cells from both lines were incubated in RPMI 1640 medium (without serum) at 37°C. Cell density was 2 x 106 ml -1. After 3 h, the samples were centrifuged at 700g for 10min and the supernatants were separated and frozen at -20°C until assayed. Prostaglandins in the supernatants were determined by direct radioimmunoassay (Granstrom & Kindhal, 1976) . The radiolabelled prostaglandins and the antibodies for 6-keto-PGF1I
and for thromboxane B2 were purchased from New England Nuclear (Boston, Ma). The antibody for PGE2 was purchased from Accurate Chemicals and Scientific Co., (New York, NY Nitrobenzylthioinosine, another blocker of adenosine transport (Lauzon & Paterson, 1977) , at the highest non-inhibitory concentration (3 x 10-6M), did not affect the sensitivity of either cell line to doxorubicin.
Discussion
The present experiments have shown that the parent P388 cell line, a methylcholanthrene-induced lymphoid neoplasm in DBA/2 mouse (Dawe & Potter, 1957) , have measurable 5'nucleotidase activity. This activity is much lower than that measured in normal DBA/2 mouse lymphocytes (Uusitalo & Karnovsky, 1977) . The activity of 5'-nucleotidase measured in the doxorubicin-resistant subline, selected by the drug from the parent P388 cell population, was significantly higher than that measured in the parent cell line and was not significantly different from the activity reported for normal DBA/2 mouse lymphocytes. The activity of this enzyme in either cell line was not affected by prior incubation of the cells in the presence of adenosine or AMP.
The increased activity of 5'-nucleotidase measured in doxorubicin-resistant cells, compared to drug-sensitive cells, may represent an increase in the amount of enzyme protein or an increase in its specific activity as a result of some change in the protein structure or its relation to other constituents of the cell membrane. After solubilization with a detergent, an increase in 5'-nucleotidase activity was measured. However, similar increase in enzyme activity was obtained in both cell lines. A detergent may on one hand increase membrane-bound enzyme activity by increasing its exposure (Solomonson et al., 1976 ) and on the other hand, may disrupt some enhancing effect of the lipid/protein interaction (Englehard et al., 1976) . Therefore this negative result does not support either possibility.
Although this study gives further support for the suggested relationship between the level of activity of 5'-nucleotidase, a membrane-bound enzyme, and the degree of structural order of the cell membrane lipid domain, the explanation for this relationship remains obscure.
The activity of 5'nucleotidase measured in human T-and B-lymphoma cell lines (Carson et al., 1979) was much lower than that reported for the corresponding normal human T-and B-lymphocytes Rowe et al., 1979) . It was suggested that the activity level of this enzyme is related to the degree of cell maturity . Decreased 5'-nucleotidase activity was reported in most chronic lymphatic leukaemias (Lopez et al., 1973; Marique & Hildebrand, 1973; Quagliata et al., 1974; Kramers et al., 1976) , in lymphocytes of immunodeficient patients with hypogammaglobulinemia (Johnson et al., 1977; Edwards et al., 1978; Webster et al., 1978) , T cell lymphoblastic leukaemias (Reaman et al., 1979) and B cell acute lymphoblastic leukaemias . It was suggested that the activity of this enzyme may be used as a new biological marker of certain diseases (Koya et al., 1981) . Our data clearly point toward the possibility that following drug treatment and the emergence of drug-resistant cell populations, the activity of 5'-nucleotidase in the remaining tumour cells may change considerably and an increase in the enzyme activity in the remaining cells may not necessarily indicate a shift toward higher differentiation. Doxorubicin-resistant P388 cells release more prostaglandin PGE2, thromboxane and prostacyclin than drug-sensitive P388 cells. The differences in arachidonate metabolism may reflect change in the availability of arachidonic acid in these cells as a part of the changes in cell lipid composition (Ramu et al., 1983b) . However, in preliminary experiments where arachidonic acid was added in excess to the incubation medium, the differences in arachidonate metabolism were maintained. This indicates that the change in arachidonate metabolism is caused by changes in the activity of certain enzymes involved in arachidonate metabolism rather than a difference in the availability of arachidonic acid.
At equicytostatic concentrations of doxorubicin (ED50), the release of PGE2 from drug-resistant P388 cells was significantly less influenced by the presence of doxorubicin than its release from drugsensitive cells. Therefore, we suggest that the inhibition of release of PGE2 by the drug is unrelated to its cytostatic effect. Furthermore as indomethacin did not change the sensitivity of either cell line to doxorubicin, we suggest that the increase in arachidonate metabolism is not the cause of doxorubicin resistance but rather reflects changes in the membrane structure of these cells. Changes in other membrane related activities were found in drug resistant cells as: glycosidase (Bosmann & Kessel, 1970) , membrane glycoproteins (Beck et al., 1979) , high macromolecular lipid (Taylor et al., 1981) and carrier-mediated uptake of methotrexate (Kessel et al., 1965; Herman et al., 1979) . In the present study we have also noted that these cell lines differ in another carrier-mediated uptake system of the cell membrane, namely the uptake of adenosine. The rate of adenosine transport was significantly higher in doxorubicinresistant cells than in drug-sensitive cells. In both cell lines the uptake could be blocked by a specific adenoside transport blocker, nitrobenzyladenosine. The finding that nitrobenzylthioinosine, another potent inhibitor of nucleosine transport (Lauzon et al., 1977) , did not change the sensitivity of either cell line to doxorubucin, suggests that the increase in adenosine uptakes is not the cause of drug resistance, but rather another reflection of the change in membrane structure.
